Correlation Between Entera Bio and Aridis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Entera Bio and Aridis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and Aridis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and Aridis Pharmaceuticals, you can compare the effects of market volatilities on Entera Bio and Aridis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of Aridis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and Aridis Pharmaceuticals.
Diversification Opportunities for Entera Bio and Aridis Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Entera and Aridis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and Aridis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aridis Pharmaceuticals and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with Aridis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aridis Pharmaceuticals has no effect on the direction of Entera Bio i.e., Entera Bio and Aridis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Entera Bio and Aridis Pharmaceuticals
If you would invest 95.00 in Entera Bio on November 9, 2024 and sell it today you would earn a total of 157.00 from holding Entera Bio or generate 165.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Entera Bio vs. Aridis Pharmaceuticals
Performance |
| Timeline |
| Entera Bio |
| Aridis Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Entera Bio and Aridis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entera Bio and Aridis Pharmaceuticals
The main advantage of trading using opposite Entera Bio and Aridis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, Aridis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aridis Pharmaceuticals will offset losses from the drop in Aridis Pharmaceuticals' long position.| Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
| Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |